Sarepta Therapeutics, Inc. (SRPT) Operating margin 2016–2025
Sarepta Therapeutics, Inc. (SRPT) operating margin by fiscal year — reported operating income divided by reported revenue.
-37.5%FY2025 · since FY2016: -4920.3% → -37.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -37.5% | -49.7 pp |
| FY2024 | 12.2% | +35.6 pp |
| FY2023 | -23.4% | +40.2 pp |
| FY2022 | -63.5% | +11.5 pp |
| FY2021 | -75.1% | +48.7 pp |
| FY2020 | -123.8% | +61.5 pp |
| FY2019 | -185.3% | -71.1 pp |
| FY2018 | -114.1% | -3.1 pp |
| FY2017 | -111.0% | +4809.3 pp |
| FY2016 | -4920.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice